Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/antibiotics10081000 http://scihub22266oqcxt.onion/10.3390/antibiotics10081000 34439050!8388979!34439050     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Antibiotics+(Basel) 2021 ; 10 (8): ä Nephropedia Template TP {{tp|p=34439050|t=2021. Gram-Positive Pneumonia: Possibilities Offered by Phage Therapy |pdf=|usr=}}{{34439050}} gab.com Text Gram-Positive Pneumonia: Possibilities Offered by Phage Therapy JO: Antibiotics (Basel) http://www.kidney.de/pget.php?&tw=1&pmid=34439050 #FOAvip Pneumonia is an acute pulmonary infection whose high hospitalization and mortality rates can, on occasion, bring healthcare systems to the brink of collapse. Both viral and bacterial pneumonia are uncovering many gaps in our understanding of host-pathogen interactions, and are testing the effectiveness of the currently available antimicrobial strategies. In the case of bacterial pneumonia, the main challenge is antibiotic resistance, which is only expected to increase during the current pandemic due to the widespread use of antibiotics to prevent secondary infections in COVID-19 patients. As a result, alternative therapeutics will be necessary to keep this disease under control. This review evaluates the advantages of phage therapy to treat lung bacterial infections, in particular those caused by the Gram-positive bacteria Streptococcus pneumoniae and Staphylococcus aureus, while also highlighting the regulatory impediments that hamper its clinical use and the difficulties associated with phage research. Twit Text FOAVip Gram-Positive Pneumonia: Possibilities Offered by Phage Therapy ????Antibiotics (Basel) http://www.kidney.de/pget.php?&tw=1&pmid=34439050 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34439050 #FOAvip English Wikipedia <ref>{{Cite pmid|34439050}}</ref> Gram-Positive Pneumonia: Possibilities Offered by Phage Therapy #MMPMID34439050 Fernandez L; Cima-Cabal MD; Duarte AC; Rodriguez A; Garcia-Suarez MDM; Garcia P Antibiotics (Basel) 2021[Aug]; 10 (8): ä PMID34439050show ga Pneumonia is an acute pulmonary infection whose high hospitalization and mortality rates can, on occasion, bring healthcare systems to the brink of collapse. Both viral and bacterial pneumonia are uncovering many gaps in our understanding of host-pathogen interactions, and are testing the effectiveness of the currently available antimicrobial strategies. In the case of bacterial pneumonia, the main challenge is antibiotic resistance, which is only expected to increase during the current pandemic due to the widespread use of antibiotics to prevent secondary infections in COVID-19 patients. As a result, alternative therapeutics will be necessary to keep this disease under control. This review evaluates the advantages of phage therapy to treat lung bacterial infections, in particular those caused by the Gram-positive bacteria Streptococcus pneumoniae and Staphylococcus aureus, while also highlighting the regulatory impediments that hamper its clinical use and the difficulties associated with phage research. äGram-Positive Pneumonia: Possibilities Offered by Phage Therapy (epmc).pdf DeepDyve Pubget Overpricing